白云山交7年来最差利润“成绩单” :金戈不振、凉茶遇冷

第一财经
17 Mar

在经历了去年反腐风波之后,全国最大的制药企业集团之一白云山(600332.SH;00874.HK)最近公布了2024年业绩“成绩单”。年报显示:上市公司白云山2024年营利双降,营收约749.93亿元,同比下降0.69%;净利润约28.35亿元,同比下降30.09%。此业绩水平,创近七年以来新低。  厚达330多页的白云山2024年报向外界传递的信息是:公司基本业务面受到较大影响,核心竞争力遭遇...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10